Talaris Therapeutics (TALS) Dividend Yield, Date & History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free TALS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share DividendStock AnalysisCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSocial Media Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Talaris Therapeutics Dividend History by QuarterAnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date10/19/2023$1.511810/20/202310/16/202310/20/2023(Data available from 1/1/2013 forward) More Dividend Resources from MarketBeat Dividend Tools: Dividend Stocks Overview Dividend Investing Guide Dividend Newsletter Dividend Screener Dividend Capture Stocks Dividend Calculator (Web) Dividend Calculator (Excel) Dividend Payout Ratio Calculator Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Dividend Announcements Dividend Increases Dividend Cuts Special Dividends Stock Lists: Best Dividend Stocks Blue Chip Stocks Cheap Dividend Stocks Dividend Achievers Dividend Aristocrats Dividend Challengers Dividend Champions Dividend Contenders Dividend ETFs Dividend Kings High-Yield REITs High-Yield Stocks Monthly Dividend Stocks Real Estate Investment Trusts Latest Articles: Alphabet Changes the Narrative with Its First-Ever Dividend3 High Dividend Stocks to Replace Lower Savings Yields Ahead3 Small Dividend Paying Banks Insiders are BuyingProfit pillars: 5 Dividend aristocrats for reliable incomeHigher VIX just made Realty Income’s 6% dividend better2 more high-quality dividend growers to buy on the dipCoca-Cola: Top-Rated dividend stock breaks out ahead of earningsBP stock looks bullish on high dividend yield, new CEO3 high-quality dividend growers to buy on the dip More Dividend News This page (NASDAQ:TALS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
